Ovation.io and Illumina Collaborate to Advance Genomic Data Research
December 17, 2024
PORTLAND, ME – Ovation.io, Inc. an organization dedicated to building best in class multi-omics datasets, today announced a collaboration with Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, that will work to accelerate advancements in precision medicine. The collaboration will address challenges in drug development by harnessing the power of genomic data to [...]
Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program
December 17, 2024
FRAMINGHAM, Mass. -- Complete Genomics, a San Jose, California based genomics tools manufacturer, today announced Framingham, Massachusetts based Eurofins Clinical Enterprise, LLC as the newest addition to its Sequencing Service Provider Program. Complete Genomics' Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ™ sequencing platforms. As part of the [...]
HunterLab Unveils the Next-Gen ColorFlex L2 Spectrophotometer/Colorimeter
December 17, 2024
RESTON, Va. -- HunterLab, a global leader in color measurement technology for over 70 years, proudly announces the launch of the ColorFlex L2 Spectrophotometer/Colorimeter. This cutting-edge device is set to redefine color accuracy and user experience in quality control processes across a variety of industries. Get more information here: https://www.hunterlab.com/en/products/benchtop-spectrophotometers/colorflex-l2/ Level UP Your Color Confidence The ColorFlex [...]
Polymer Factory signs distribution agreement for SpheriCal® in Japan
December 17, 2024
Polymer Factory Sweden AB (publ) today announces that the Company has signed a distribution agreement with Japanese company AMR Inc. for resale of its SpheriCal® platform in Japan. Polymer Factory has signed a non-exclusive distribution agreement with AMR, covering the Company’s SpheriCal® platform, including the most recently launched SpheriCal® IM-MS products. No financial commitment has [...]
BioLife Solutions Appoints Tony J. Hunt to its Board of Directors
December 16, 2024
BOTHELL, Wash. -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces the appointment of Tony J. Hunt, Executive Chairman of Repligen Corporation (Nasdaq: RGEN) and a recognized leader in bioprocessing innovation, to its board of directors effective January 2, 2025. [...]
bit.bio Raises $30 Million Led by M&G Investments
December 16, 2024
bit.bio Raises $30 Million Led by M&G Investments to Focus on Tools for the Research, Drug Discovery and Cell Therapy Markets. Jonathan Milner Appointed Interim CEO; Mark Kotter Assumes Vice Chairman Role as Company Expands Board with Distinguished Biotech Leaders. Cambridge, UK – bit.bio, the global leader in cell programming technology, today announced the successful [...]
December 16, 2024
Shimadzu Corporation has signed an investment contract with U-Medico Inc, (head office: Osaka prefecture; hereinafter U-Medico), a contract research organization (CRO). In accordance with this investment, from December 2024, Shimadzu has collaboratively developed a gene therapy pharmaceuticals manufacturing platform aimed at pharmaceutical companies, contract development and manufacturing organizations (CDMO), and educational & research institutions, and [...]
December 16, 2024
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, today announced that NF Validation (AFNOR) has approved the extension of certification of the iQ-Check™ Listeria spp. and iQ-Check™ Listeria monocytogenes Kits for the real-time PCR detection of Listeria spp. and Listeria monocytogenes in food products for human consumption and in environmental samples [...]
December 15, 2024
A groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness. SequenceME will bring together experts from Oxford Nanopore Technologies, Action for ME, and the University of Edinburgh, to uncover the root causes of ME and to [...]
Sepragen Corporation Receives ISO 9001:2015 Certification
December 13, 2024
UNION CITY, Calif. -- Sepragen Corporation, a leader in innovative bioprocessing technologies, is proud to announce that it has achieved ISO 9001:2015 certification, the internationally recognized standard for quality management systems. This milestone demonstrates Sepragen’s unwavering commitment to delivering high-quality products and services that meet the rigorous standards of the bioprocessing industry. The ISO 9001:2015 [...]

